Richard Pazdur Discusses FDA Chaos in Full Video Session
Richard Pazdur, a prominent figure at the Food and Drug Administration (FDA) until recently, raised concerns about the agency’s current state during an event in San Francisco. This event coincided with the J.P. Morgan Healthcare Conference.
Concerns Over Political Influence at the FDA
Pazdur, who previously led the FDA’s oncology center, highlighted alarming trends regarding the erosion of the separation between political appointees and scientific drug reviewers. He emphasized the importance of maintaining this firewall to ensure objective drug evaluations.
Issues with Transparency
Another significant concern raised by Pazdur involved a new voucher program linked to accelerated drug reviews. This program allows certain drugs to be fast-tracked based on decisions made by officials from the Trump administration.
- Pazdur described the lack of transparency surrounding this program as troubling.
- He mentioned, “It’s terrible to see 25 years of work dismantled.”
Pazdur’s Departure from the FDA
Richard Pazdur’s exit from the FDA has stirred discussions within the pharmaceutical community. He clarified that his departure was not a decision he desired. His insights shed light on the growing concerns of regulatory integrity at the agency.
As the conversation around FDA practices continues, Pazdur’s reflections are likely to prompt further scrutiny into how political factors are influencing drug approval processes.
For those interested, the full session featuring Richard Pazdur’s remarks is available for viewing.
The post Richard Pazdur Discusses FDA Chaos in Full Video Session appeared first on CDN3 - Filmogaz.
